We are live on ! Find out more
TTP

TITAN PHARMACEUTICAL INC
TTP

Delisted

TTP was delisted on the 24th of December, 2008.

3 hedge funds and large institutions have $330K invested in TITAN PHARMACEUTICAL INC in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $221K → $330K (+$108K)

0% more funds holding

Funds holding: 33 (0)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
+$6.07K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
GS
1
Gagnon Securities
New York
$327K +$6.07K +9,030 +2%
HRIA
2
Haberer Registered Investment Advisor
Ohio
$2K
ECM
3
Estabrook Capital Management
New York
$671

TTP Hedge Fund Activity: Q3 2013 in Review

3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q3 2013, worth a combined $330K — up 49% from $221K a quarter earlier.

Fund positioning in TTP was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Gagnon Securities, adding an estimated $6.07K.

  • 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $330K of TITAN PHARMACEUTICAL INC stock for Q3 2013, up 49% quarter-over-quarter.
  • 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q3 2013 and 0 closed out.
  • The largest TITAN PHARMACEUTICAL INC buyer in Q3 2013 was Gagnon Securities, an estimated $6.07K added.

Based on aggregated 13F filings for Q3 2013.